Coronavirus: AstraZeneca vaccine safe even after seven blood clot deaths, says UK medical regulator
- The reports of thrombosis, submitted by doctors or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country
- The Medicines and Healthcare products Regulatory Agency and European Medicines Agency say no causal link has been established between blood clotting cases and the AstraZeneca vaccine
The UK medical regulator said on Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.
The British acknowledgement of deaths comes as several European countries have paused the use of the AstraZeneca jab over a potential link to blood clots.
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) said in a statement that “out of the 30 reports up to and including 24 March, sadly seven have died.”
The reports of thrombosis, submitted by doctors or members of the public via a government website, came after 18.1 million doses of the vaccine had been administered in the country.
Most of the cases (22) were a rare clotting condition called cerebral venous sinus thrombosis. Eight cases saw people suffer other types of thrombosis combined with low levels of blood platelets, which help blood clot.
There were no reports of blood clots from the Pfizer-BioNTech vaccine, the UK regulator said, adding that “our thorough review into these reports is ongoing”.
But MHRA chief executive Dr June Raine stressed that the benefits far outweighed any risks. “The public should continue to get their vaccine when invited to do so,” she said.
